Literature DB >> 6174666

Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein.

D L Hasty, E H Beachey, W A Simpson, J B Dale.   

Abstract

Hybridoma technology was used to produce a set of monoclonal antibodies against a purified polypeptide fragment of type 24 streptococcal M protein to delineate the protective determinants of M protein exposed on the surface of the virulent streptococci. Several hybridoma antibodies were found to be opsonic against the homologous type streptococci. At least two of these antibodies (IIC3.7 and IIC4.6) protected mice against challenge infections with the homologous, but not a heterologous, serotype of bacteria. One of the hybridoma antibodies that reacted in high dilution (1:204,800) with the isolated M protein failed to react with the M protein on the surface of type 24 streptococci, and thus did not opsonize the homologous organisms or protect mice against challenge infections. Because hybridoma antibodies are directed against a single distinct immunodeterminant, these results indicate that protective immunity may be directed at any one of several distinct antigenic determinants of M protein exposed on the surface of virulent group A streptococci.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174666      PMCID: PMC2186657          DOI: 10.1084/jem.155.4.1010

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins.

Authors:  E H Beachey; M Cunningham
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

3.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

4.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

5.  Immunochemical properties of streptococcal M protein purified by isoelectric focusing.

Authors:  M Cunningham; E H Beachey
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

6.  Opsonic capacity of type specific streptococcal antibodies.

Authors:  I Ofek; S Bergner-Rabinowitz; A M Davies
Journal:  Isr J Med Sci       Date:  1969 May-Jun

7.  Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules.

Authors:  V A Fischetti; E C Gotschlich; G Siviglia; J B Zabriskie
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

8.  An immunological relationship between the group. A streptococcus and mammalian muscle.

Authors:  J B Zabriskie; E H Freimer
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

9.  Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood.

Authors:  E H Beachey; G H Stollerman
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

10.  Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen.

Authors:  E H Beachey; G H Stollerman; E Y Chiang; T M Chiang; J M Seyer; A H Kang
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

View more
  17 in total

1.  Generation of monoclonal antibodies to the zinc finger domain of the eukaryotic transcription factor Sp1.

Authors:  H Katai; K Terato; R Raghow
Journal:  Mol Cell Biochem       Date:  1991-02-27       Impact factor: 3.396

2.  Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.

Authors:  T F Eckert; T R Kozel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

3.  Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant.

Authors:  E H Beachey
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

Review 4.  Monoclonal antibodies for the diagnosis of infectious diseases.

Authors:  M C Harris
Journal:  Indian J Pediatr       Date:  1987 Jul-Aug       Impact factor: 1.967

5.  Strategies for prevention and control of rheumatic fever and rheumatic heart disease.

Authors:  U Kaul; K S Reddy; M L Bhatia
Journal:  Indian J Pediatr       Date:  1983 Jul-Aug       Impact factor: 1.967

6.  Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies.

Authors:  J B Dale; E H Beachey
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG.

Authors:  P Minden; P J Kelleher; J H Freed; L D Nielsen; P J Brennan; L McPheron; J K McClatchy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.

Authors:  E H Beachey; A Tartar; J M Seyer; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  A Neutralizing Monoclonal IgG1 Antibody of Platelet-Activating Factor Acetylhydrolase SsE Protects Mice against Lethal Subcutaneous Group A Streptococcus Infection.

Authors:  Mengyao Liu; Wenchao Feng; Hui Zhu; Benfang Lei
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

10.  Heterogeneity among human collagenases demonstrated by monoclonal antibody that selectively recognizes and inhibits human neutrophil collagenase.

Authors:  K A Hasty; M S Hibbs; A H Kang; C L Mainardi
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.